Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000152769 | SCV000202157 | benign | not specified | 2018-02-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000152769 | SCV000517779 | benign | not specified | 2015-12-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome Diagnostics Laboratory, |
RCV000625087 | SCV000743747 | likely benign | ALG1-congenital disorder of glycosylation | 2015-01-07 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625087 | SCV000745151 | benign | ALG1-congenital disorder of glycosylation | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV001258273 | SCV001435198 | benign | Kabuki syndrome 1 | criteria provided, single submitter | research | The p.Ser267Asn variant in ALG1 has been identified in 1 individual with congenital disorder of glycosylation (PMID: 23806237). However, this variant is classified as benign for autosomal recessive congenital disorder of glycosylation because it has been identified in >25% of Latino chromosomes by ExAC (http://gnomad.broadinstitute.org/). | |
Invitae | RCV000625087 | SCV001728179 | benign | ALG1-congenital disorder of glycosylation | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000152769 | SCV002050996 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing |